SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-018795
Filing Date
2024-05-13
Accepted
2024-05-13 08:10:57
Documents
66
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 827549
2 ex10-1.htm EX-10.1 88418
3 ex10-2.htm EX-10.2 50563
4 ex31-1.htm EX-31.1 20465
5 ex31-2.htm EX-31.2 19822
6 ex32-1.htm EX-32.1 8911
  Complete submission text file 0001493152-24-018795.txt   4487085

Data Files

Seq Description Document Type Size
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imnn-20240331.xsd EX-101.SCH 32061
8 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imnn-20240331_cal.xml EX-101.CAL 47031
9 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imnn-20240331_def.xml EX-101.DEF 117169
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imnn-20240331_lab.xml EX-101.LAB 320733
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imnn-20240331_pre.xml EX-101.PRE 246833
70 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 533250
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 24936981
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)